GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SQZ Biotechnologies SQZB · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.02

—

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

SQZ Biotechnologies — daily SQZB Delayed
Market value
$707,760
Last close × shares
Volume
200
Shares, 6 Nov 2026

About SQZ Biotechnologies

Its shares trade under the ticker SQZB. It has been listed since 30 October 2020. In the fiscal year to 31 December 2023, it reported revenue of $12.2m and a net loss of $71.6m.

SQZ Biotechnologies Co. is a clinical-stage biotechnology company, which engages in developing cell therapies for patients with cancer, infectious diseases, and other serious conditions. The company is headquartered in Watertown, Massachusetts. The company went IPO on 2020-10-30. The firm is focused on unlocking the full potential of cell therapies to benefit patients. In oncology, it is developing cell therapy platforms that are based on directing tumor antigen-specific immune activation via engineered antigen presentation. Its clinical-stage cell therapy candidates include SQZ Enhanced APC (eAPC) Platform, SQZ Activating Antigen Carrier (AAC) Platform and SQZ Tolerizing Antigen Carrier (TAC) Platform. The SQZ eAPC platform is the second-generation product candidate designed to generate tumor specific CD8+ T cell activation to drive the antitumor immune response. The SQZ AAC platform is designed to induce antigen presentation in vivo by deriving antigen carriers from engineering red blood cells (RBCs) with tumor specific antigens and adjuvants. Its SQZ TAC platform is designed to induce antigen-specific immune tolerance in vivo by utilizing a similar approach to the AAC platform.

Figures and description from our data supplier, not checked against the company's own report.

More about SQZ Biotechnologies →

Latest on SQZ Biotechnologies

Our reporting

We have not reported on SQZ Biotechnologies yet.

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -0.58 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is SQZ Biotechnologies's ticker?

SQZ Biotechnologies trades as SQZB on its US listing, under ISIN US78472W1045.

What was SQZ Biotechnologies's last closing price?

0.02 on 6 Nov 2026. The figure is in USD and is never converted.

When does SQZ Biotechnologies next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.